Q1 2023 InsurTech Sector Flourishes: Boosted Investments and Innovative Growth

The InsurTech industry has bounced back strongly in the first quarter of 2021, with global investments reaching $1.39 billion, according to the latest Global InsurTech Report from Gallagher Re. This marks a 37.6% increase from the previous quarter’s lowest total since Q1 2020, indicating a strong recovery for the industry. The report also highlights some interesting trends in the industry, including steady deal counts, increased average deal sizes, and more.

Steady deal count, but average deal size increases

Despite the pandemic’s impact on the economy, the deal count for InsurTech funding remained steady, suggesting that investors remain optimistic about the industry’s future. However, what is particularly positive news is that the average deal size increased by 25.3%, indicating more significant commitments from investors.

Mega-Round Funding Accounts for Only 12.9% of Total

While mega-round funding (investment rounds of $100 million or more) can often skew the overall funding numbers for an industry, the report shows that mega-round funding for InsurTech companies accounted for only 12.9% of the total in Q1 2021. This is the lowest percentage since the dip experienced in Q1 2020.

P&C insurtech funding drives increase in quarterly investment

The report found that Property and Casualty (P&C) InsurTech funding was the driving force behind the increase in quarterly investment, surging by more than 53% to $967.89 million in Q1 2021. This increase is likely due to the ongoing demand for innovative solutions to the challenges facing the insurance industry, such as automation and improved underwriting capabilities.

L&H Fundraising also grows

Life and Health (L&H) fundraising also grew, rising 9.6% to $420.73 million. This increase occurred despite early-stage L&H funding seeing a decline of 44.3% relative to the previous quarter. However, the average early-stage deal was up by 28% to $8.31 million. This suggests that while there may be fewer early-stage deals, the ones that do happen are larger and more significant.

Potential return to pre-pandemic levels of InsurTech funding

The latest funding totals suggest that 2023 may mark a return to the more ‘normal’ levels of gently rising InsurTech funding that were experienced before the pandemic. According to Simon Johnston, Head of InsurTech at Gallagher, “Funding is back to pre-pandemic levels, and the sector is set to prove its worth, with investors convinced of the long-term potential.”

Founders are focusing on long-term sustainability and growth

As the pandemic continues to disrupt industries worldwide, founders of InsurTech startups are now thinking about long-term sustainability and growth. The report suggests that founders are realizing their businesses will need to “pull the plow” themselves, relying on their capabilities and revenues. This is a positive sign for the industry, indicating a focus on sustainability rather than short-term gains.

The InsurTech industry has proven its resilience and adaptability over the past year, with Q1 2021 marking a strong rebound in funding and continued optimism from investors. The report suggests a potential return to pre-pandemic levels of funding, and founders are focusing on long-term sustainability and growth. This is a positive outlook for the industry, with InsurTech startups well-positioned to drive innovation and change in the insurance sector.

Explore more

Omantel vs. Ooredoo: A Comparative Analysis

The race for digital supremacy in Oman has intensified dramatically, pushing the nation’s leading mobile operators into a head-to-head battle for network excellence that reshapes the user experience. This competitive landscape, featuring major players Omantel, Ooredoo, and the emergent Vodafone, is at the forefront of providing essential mobile connectivity and driving technological progress across the Sultanate. The dynamic environment is

Can Robots Revolutionize Cell Therapy Manufacturing?

Breakthrough medical treatments capable of reversing once-incurable diseases are no longer science fiction, yet for most patients, they might as well be. Cell and gene therapies represent a monumental leap in medicine, offering personalized cures by re-engineering a patient’s own cells. However, their revolutionary potential is severely constrained by a manufacturing process that is both astronomically expensive and intensely complex.

RPA Market to Soar Past $28B, Fueled by AI and Cloud

An Automation Revolution on the Horizon The Robotic Process Automation (RPA) market is poised for explosive growth, transforming from a USD 8.12 billion sector in 2026 to a projected USD 28.6 billion powerhouse by 2031. This meteoric rise, underpinned by a compound annual growth rate (CAGR) of 28.66%, signals a fundamental shift in how businesses approach operational efficiency and digital

du Pay Transforms Everyday Banking in the UAE

The once-familiar rhythm of queuing at a bank or remittance center is quickly fading into a relic of the past for many UAE residents, replaced by the immediate, silent tap of a smartphone screen that sends funds across continents in mere moments. This shift is not just about convenience; it signifies a fundamental rewiring of personal finance, where accessibility and

European Banks Unite to Modernize Digital Payments

The very architecture of European finance is being redrawn as a powerhouse consortium of the continent’s largest banks moves decisively to launch a unified digital currency for wholesale markets. This strategic pivot marks a fundamental shift from a defensive reaction against technological disruption to a forward-thinking initiative designed to shape the future of digital money. The core of this transformation